In a major breakthrough, scientists have developed a genetically engineered maize strain capable of secreting human anti-bodies against cancer. According to a report published in the science journal, Scientific American, the 'plantbodies' secreted by the corn cells when purified and injected in a dose of 250 mg in cancer patients will stick to tumour cells and deliver the radio isotopes thereby killing the diseased cells. By transplanting a human gene in corn reproductive cells and adding other DNA that cranks up the cells production of foreign protein, American biotechnology firm, Agracetus, has created a strain that would yield about 1.5 kg of pharmaceutical quality antibodies per acre of corn.